Elanor Brammer

Elanor Brammer began her scientific career at the University of Strathclyde with a Master's degree in Pure and Applied Chemistry from the Faculty of Science. This degree included a placement within an industry setting for the duration of year 4, followed by a reasearch project within one of the University chemistry departments for the final year of study. It was during her time at AstraZeneca for her industrial placement that her passion for pharmaceutical manufacturing was first recognised, and the desire to pursue this via a research setting was further nurtured within an academic research laboratory environment.

Elanor joined The EPSRC Doctoral Training Centre for Continuous Manufacturing and Crystallisation (CMAC), under the supervision of Prof. Gavin Halbert, in October 2013. Her project is titled 'Scaleable Oral Dose Formulations' and aims to provide novel solutions within the rapidly growing field of personalised medicine. With the extreme diversity of human beings as a species, there are many different factors which can influence the behaviour of a drug within the body. As such, a shift in the current pharmaceutical manufacturing practises towards a more individualised approach is thought to be the best solution for accommodating this variety. In order to achieve easily scalable dose formulations, methods such as Hot-Melt Extrusion and Fused Filament Fabrication were utilised within her project to provide the required flexibility of dosing. It is hoped that this research can provide a starting point for further advances in a more sustainable and personalised future for pharmaceutical manufacturing.